Advisories and Alerts

The American College of Obstetricians and Gynecologists (ACOG) Practice Advisories are issued whenever information on a clinical issue requiring a rapid response is released. Below are recent ACOG Practice Advisories that may be of importance to our TCHMB readers and collaborators. (See also Withdrawn Practice Advisories.)

Practice Advisory: Hepatitis B Prevention

A critical element of the strategy to eliminate HBV in the United States is the prevention of perinatal transmission. 

Practice Advisory: Management of Uterine Leiomyomas (Fibroids)

On December 14, 2017, the Agency for Healthcare Research and Quality (AHRQ) released a comparative effectiveness review on the management of uterine fibroids. 

Practice Advisory: Hormonal Contraception and Risk of Breast Cancer

On December 7, 2017, a cohort study analyzing the risk of invasive breast cancer in women who used hormonal contraception was published in the New England Journal of Medicine. 

Practice Advisory: Influenza Vaccination During Pregnancy

In evaluating all the available scientific information, the results from the September 2017 study do not warrant changing the current recommendation.

Practice Advisory: FDA Removal of Boxed Warning on Varenicline and Bupropion

If these medications are used, obstetrician-gynecologists should be aware of the benefits and risks associated with these medications.